{"id":142226,"date":"2022-07-14T22:23:53","date_gmt":"2022-07-15T03:23:53","guid":{"rendered":"https:\/\/lifeboat.com\/blog\/2022\/07\/biontech-pfizer-to-start-testing-universal-vaccine-for-coronaviruses"},"modified":"2022-07-14T22:23:53","modified_gmt":"2022-07-15T03:23:53","slug":"biontech-pfizer-to-start-testing-universal-vaccine-for-coronaviruses","status":"publish","type":"post","link":"https:\/\/lifeboat.com\/blog\/2022\/07\/biontech-pfizer-to-start-testing-universal-vaccine-for-coronaviruses","title":{"rendered":"BioNTech, Pfizer to start testing universal vaccine for coronaviruses"},"content":{"rendered":"<p><a class=\"aligncenter blog-photo\" href=\"https:\/\/lifeboat.com\/blog.images\/biontech-pfizer-to-start-testing-universal-vaccine-for-coronaviruses2.jpg\"><\/a><\/p>\n<p>June 29 (Reuters) \u2014 Germany\u2019s BioNTech <a data-testid=\"Link\" href=\"https:\/\/www.reuters.com\/companies\/22UAy.DE\" target=\"_blank\" class=\"\">(22UAy. DE)<\/a>, Pfizer\u2019s <a data-testid=\"Link\" href=\"https:\/\/www.reuters.com\/companies\/PFE.N\" target=\"_blank\" class=\"\">(PFE.N)<\/a> partner in COVID-19 vaccines, said the two companies would start tests on humans of next-generation shots that protect against a wide variety of coronaviruses in the second half of the year.<\/p>\n<p>Their experimental work on shots that go beyond the current approach include T-cell-enhancing shots, designed to primarily protect against severe disease if the virus becomes more dangerous, and pan-coronavirus shots that protect against the broader family of viruses and its mutations.<\/p>\n<p>In presentation slides posted on BioNTech\u2019s website for its investor day, the German biotech firm said its aim was to \u201cprovide durable variant protection\u201d.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>June 29 (Reuters) \u2014 Germany\u2019s BioNTech (22UAy. DE), Pfizer\u2019s (PFE.N) partner in COVID-19 vaccines, said the two companies would start tests on humans of next-generation shots that protect against a wide variety of coronaviruses in the second half of the year. Their experimental work on shots that go beyond the current approach include T-cell-enhancing shots, [\u2026]<\/p>\n","protected":false},"author":513,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[11],"tags":[],"class_list":["post-142226","post","type-post","status-publish","format-standard","hentry","category-biotech-medical"],"_links":{"self":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/142226","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/users\/513"}],"replies":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/comments?post=142226"}],"version-history":[{"count":0,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/142226\/revisions"}],"wp:attachment":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/media?parent=142226"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/categories?post=142226"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/tags?post=142226"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}